Showing results (51-60 of 264) with videos related to

Sort By:
Pageof 27
Haematologica|January 19, 2011
Chronic lymphocytic leukemia and autoimmunity: a systematic reviewKate Hodgson, Gerardo Ferrer, Emili Montserrat, et al.
Best Practice & Research. Clinical Haematology|August 21, 2007
The role of stem-cell transplantation in chronic lymphocytic leukemia risk-adapted therapyEva Giné, Carol Moreno, Jordi Esteve, et al.
Haematologica|April 28, 2010
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behaviorEva Giné, Antoni Martinez, Neus Villamor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapySilvia Marcé, Olga Balagué, Luis Colomo, et al.
Expert Review of Hematology|February 17, 2011
Personalizing treatment for chronic lymphocytic leukemiaPau Abrisqueta, Marta Crespo, Francesc Bosch
Cancer Research|December 17, 2008
Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemiaAnna Enjuanes, Yolanda Benavente, Francesc Bosch, et al.
Haematologica|June 13, 2003
International and Italian prognostic indices in follicular lymphomaGranada Perea, Albert Altés, Silvia Montoto, et al.
Haematologica|March 8, 2005
Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategiesMarco Montillo, Terry Hamblin, Michael Hallek, et al.
British Journal of Haematology|May 4, 2011
Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatmentKate Hodgson, Gerardo Ferrer, Arturo Pereira, et al.
Annals of Hematology|August 11, 2021
Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysisGuillermo Villacampa, Rodrigo Dienstmann, Francesc Bosch, et al.
Pageof 27